Literature DB >> 6352625

Multiple dose pharmacokinetics and therapeutic results with ceftazidime.

H Warns, H Lode, C M Harnoss, B Kemmerich, P Koeppe, J Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6352625     DOI： 10.1093/jac/12.suppl_a.235

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  High-pressure liquid chromatographic analysis of BMY-28142 in plasma and urine.

Authors:  R H Barbhaiya; S T Forgue; W C Shyu; E A Papp; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

2.  Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.

Authors:  H Lode; R Wiley; G Höffken; J Wagner; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Population pharmacokinetics of continuous infusion ceftazidime.

Authors:  B C Frame; B F Facca; D P Nicolau; S N Triesenberg
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

5.  Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.

Authors:  J W Mouton; A M Horrevorts; P G Mulder; E P Prens; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

6.  Dosage adjustment for ceftazidime in patients with impaired renal function.

Authors:  R van Dalen; T B Vree; A M Baars; E Termond
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Cefpodoxime proxetil in patients with endstage renal failure on hemodialysis.

Authors:  D Höffler; P Koeppe; M Corcilius; A Przyklinik
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

8.  Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.

Authors:  W Paulfeuerborn; H J Müller; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 9.  Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R N Brogden
Journal:  Drugs       Date:  1985-02       Impact factor: 9.546

10.  Convulsions following rapid ceftazidime administration for preinduction antibiotic prophylaxis during neurosurgical procedure.

Authors:  Rudrashish Haldar; Ashutosh Kaushal; Devendra Gupta; Shashi Srivastava; Prabhat K Singh; Paurush Ambesh
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.